AI in Drug Discovery Conference, 9-10 March, Hilton, Kensington, London

Memo

SAE Media Group's AI in Drug Discovery 2026 takes place 9–10 March in London. Join pharma and biotech leaders to explore how AI, ML, and generative tools are transforming drug pipelines. The agenda features case studies, clinical updates, and expert panels on target ID, computational design, and scaling AI across R and D. Discover the latest breakthroughs and connect with directors and heads of informatics, molecular design, and data science.Tickets: https://go.evvnt.com/3274167-0?pid=5569Date and Time: On Monday March 09, 2026 at 8:30 am to Tuesday March 10, 2026 at 6:00 pmVenue details: Hilton London Kensington, 179-199 Holland Park Avenue, London, England, W11 4UL, United KingdomPrices:Book by 7th November and save £400: GBP 1898.00,Book by 5th December and save £200: GBP 2098.00,Book by 9th January and save £100: GBP 2198.00Speakers: Peter Clark, VP Computational Drug Design, Novo Nordisk (Chair), James Lumley, Head of Cheminformatics, GSK, Le (Muller) Mu, MLOps Lead, Computational Sciences Centre of Excellence, gRED, Roche, Dr. Pedro J Ballester, Royal Society Wolfson Fellow and Associate Professor, Department of Bioengineering, Imperial College, University of London, Thierry Dorval    Head of Data Science and Data Management, Servier, Lewis Vidler, Senior Director – Structure Based Drug Design, Eli Lilly and Company, Tim Hohm, Associate Director, Digital Science Ext Partnerships, Novo Nordisk, Graeme Robb, Director, Computational Chemistry, AstraZeneca, Haruna Iwaoka, Head, Advanced Modelling and Assays, Innovation Lab, Astellas Pharma, Reiko Wada, Senior Scientist, Astellas Pharma, Anna Macintyre, Senior Data Scientist, Novo Nordisk, Krishna Bulusu, Senior Director, Oncology Data Science, AstraZeneca, Simone Fulle, Head CADD, Novartis (Basel), Martin Redhead, Associate VP, Primary Pharmacology, Recursion, Paul Mortenson, Senior Director, Computational Chemistry and Informatics, Astex Pharmaceuticals, Teresa De Haro, Principal Scientist, UCB, Martin Buttenschoen, Researcher, Oxford Protein Informatics Group, University of Oxford, Venkatesh Pilla Reddy, Senior Director, Global PKPD and Pharmacometrics, Eli Lilly, Christoph Grebner, AI Scientist and Computational Chemist, Sanofi, Sammeli Liikkanen, Director, Digital Medicine, Orion Pharma, Dr Yogesh Sabnis, Lead Chemist, UCB, Dr Petrina Kamya, Global Head of AI Platforms, VP, Insilico Medicine / Insilico Canada Inc.